Vojtechova Petra, Martin Richard M
Faculty of Medicine and Dentistry, University of Bristol, Bristol, UK.
Cancer Causes Control. 2009 Sep;20(7):1091-105. doi: 10.1007/s10552-009-9334-y. Epub 2009 Apr 2.
There is a long-standing interest in finding whether allergic disorders cause or prevent cancer. We meta-analyzed associations of allergies with prostate, breast, and colorectal cancers. We searched MEDLINE, EMBASE, and Web of Science between 1966 and 2008 and eligible reference lists. A total of 16 observational studies were included. Meta-analyses revealed no evidence that asthma, hay fever, or 'any allergy' are associated with cancers of the breast (relative risk, RR = 0.93, 95% CI: 0.73-1.19 for asthma; 1.04, 0.94-1.16 for hay fever; 1.01, 0.94-1.08 for any allergy); prostate (RR = 0.93, 95% CI: 0.76-1.15 for asthma; 0.96, 0.87-1.05 for hay fever; 1.01, 0.87-1.17 for any allergy); or colorectum (RR = 0.95, 95% CI: 0.77-1.16 for asthma; 0.95, 0.86-1.05 for hay fever; 0.94, 0.85-1.04 for any allergy). There was a positive association of atopy (assessed by allergen-specific IgE or skin prick testing) with prostate cancer (RR = 1.43, 95% CI: 1.08-1.91), but not breast (1.18, 0.90-1.55) or colorectal (1.32, 0.69-2.53) cancers. There is little epidemiological support for the immune surveillance theory or antigenic stimulation theory in breast or colorectal carcinogenesis. The findings for prostate cancer warrant further investigation.
长期以来,人们一直关注过敏性疾病是否会引发癌症或预防癌症。我们对过敏与前列腺癌、乳腺癌和结直肠癌之间的关联进行了荟萃分析。我们检索了1966年至2008年间的MEDLINE、EMBASE和科学网以及符合条件的参考文献列表。共纳入16项观察性研究。荟萃分析显示,没有证据表明哮喘、花粉症或“任何过敏”与乳腺癌(相对风险,RR = 0.93,95%置信区间:哮喘为0.73 - 1.19;花粉症为1.04,0.94 - 1.16;任何过敏为1.01,0.94 - 1.08)、前列腺癌(RR = 0.93,95%置信区间:哮喘为0.76 - 1.15;花粉症为0.96,0.87 - 1.05;任何过敏为1.01,0.87 - 1.17)或结直肠癌(RR = 0.95,95%置信区间:哮喘为0.77 - 1.16;花粉症为0.95,0.86 - 1.05;任何过敏为0.94,0.85 - 1.04)相关。特应性(通过过敏原特异性IgE或皮肤点刺试验评估)与前列腺癌呈正相关(RR = 1.43,95%置信区间:1.08 - 1.91),但与乳腺癌(1.18,0.90 - 1.55)或结直肠癌(1.32,0.69 - 2.53)无关。在乳腺癌或结直肠癌的致癌过程中,免疫监视理论或抗原刺激理论几乎没有流行病学支持。前列腺癌的研究结果值得进一步调查。